- Home
- Publications
- Publication Search
- Publication Details
Title
Transforming growth factor-β: A therapeutic target for cancer
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 8, Pages 1741-1750
Publisher
Informa UK Limited
Online
2017-06-03
DOI
10.1080/21645515.2017.1327107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ATRA modulates mechanical activation of TGF-β by pancreatic stellate cells
- (2016) Muge Sarper et al. Scientific Reports
- Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
- (2015) Yutaka Fujiwara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
- (2015) G. Giaccone et al. EUROPEAN JOURNAL OF CANCER
- Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
- (2015) Armin Maier et al. CELLULAR ONCOLOGY
- Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761
- (2015) Mengxian Zhang et al. NEOPLASIA
- An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial–mesenchymal transition
- (2014) Chul-Yong Park et al. CANCER LETTERS
- Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
- (2014) Jordi Rodón et al. INVESTIGATIONAL NEW DRUGS
- Expression of a Soluble TGF- Receptor by Tumor Cells Enhances Dendritic Cell/Tumor Fusion Vaccine Efficacy
- (2014) M. Zhang et al. JOURNAL OF IMMUNOLOGY
- Effective Chemoimmunotherapy with Anti-TGFβ Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer
- (2014) Xin Chen et al. PLoS One
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
- (2013) Ivelina Gueorguieva et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Peripheral TGF- 1 Signaling Is a Critical Event in Bone Cancer-Induced Hyperalgesia in Rodents
- (2013) Q. Xu et al. JOURNAL OF NEUROSCIENCE
- Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats
- (2013) Hong Ling et al. PLoS One
- TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment
- (2013) Yoko Tabe et al. PLoS One
- Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
- (2013) Francesco Dituri et al. PLoS One
- Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
- (2013) James P Stevenson et al. OncoImmunology
- Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host
- (2012) Z Zhang et al. CANCER GENE THERAPY
- Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model
- (2012) Zebin Hu et al. HUMAN GENE THERAPY
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling
- (2012) Fayth L. Miles et al. PROSTATE
- Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
- (2011) Xinhai Wan et al. BONE
- Blockade of TGF- Signaling by the TGF R-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
- (2011) M. Zhang et al. CANCER RESEARCH
- Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
- (2011) Karl-Hermann Schlingensiepen et al. CANCER SCIENCE
- TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- (2011) F. Bouquet et al. CLINICAL CANCER RESEARCH
- Oncolytic Adenovirus Expressing Soluble TGFβ Receptor II-Fc-mediated Inhibition of Established Bone Metastases: A Safe and Effective Systemic Therapeutic Approach for Breast Cancer
- (2011) Zebin Hu et al. MOLECULAR THERAPY
- Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells
- (2010) O Shinto et al. BRITISH JOURNAL OF CANCER
- Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study
- (2010) Emilia Fransvea et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TGF- -RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
- (2010) K. S. Mohammad et al. CANCER RESEARCH
- Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
- (2010) Vidya Ganapathy et al. Molecular Cancer
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity
- (2010) Tanaka ONCOLOGY REPORTS
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival
- (2009) Sana Intidhar Labidi et al. ANNALS OF HEMATOLOGY
- Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
- (2009) J Nemunaitis et al. CANCER GENE THERAPY
- Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
- (2009) Bixiang Zhang et al. CANCER LETTERS
- The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
- (2009) Jason D. Lee et al. CARCINOGENESIS
- Targeting the transforming growth factor-β signaling pathway in human cancer
- (2009) Nagathihalli S Nagaraj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antimetastatic Role of Smad4 Signaling in Colorectal Cancer
- (2009) Bixiang Zhang et al. GASTROENTEROLOGY
- Inhibition of transforming growth factor β receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation
- (2009) Antonio Mazzocca et al. HEPATOLOGY
- Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
- (2009) M Petersen et al. ONCOGENE
- TGF-β effects on airway smooth muscle cell proliferation, VEGF release and signal transduction pathways
- (2009) Joo Hwa SHIN et al. RESPIROLOGY
- Inhibition of the TGF- receptor I kinase promotes hematopoiesis in MDS
- (2008) L. Zhou et al. BLOOD
- An Anti-Transforming Growth Factor Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
- (2008) J.-S. Nam et al. CANCER RESEARCH
- TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity
- (2008) Elizabeth C. Finger et al. CARCINOGENESIS
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- External Validation of a Biomarker-Based Preoperative Nomogram Predicts Biochemical Recurrence After Radical Prostatectomy
- (2008) Shahrokh F. Shariat et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased TGF-Beta1 protein expression in patients with advanced colorectal cancer
- (2008) Marcus Langenskiöld et al. JOURNAL OF SURGICAL ONCOLOGY
- Effect of IN-1130, a Small Molecule Inhibitor of Transforming Growth Factor-β Type I Receptor/Activin Receptor-Like Kinase-5, on Prostate Cancer Cells
- (2008) Geun Taek Lee et al. JOURNAL OF UROLOGY
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
- Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
- (2007) Lorea Bueno et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started